Elsevier

Neuropharmacology

Volume 32, Issue 4, April 1993, Pages 315-321
Neuropharmacology

The dopamine D1 receptor agonist SKF 38393 suppresses detrusor hyperreflexia in the monkey with parkinsonism induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)

https://doi.org/10.1016/0028-3908(93)90151-RGet rights and content

Abstract

A pharmacological study using monkeys, in which parkinsonism was induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP), was undertaken to elucidate the mechanism underlying urinary bladder dysfunctions in Parkinson's disease. Under ketamine anesthesia, cystometrograms showed that, in MPTP-treated monkeys, a contraction of the urinary bladder was induced with smaller bladder volume than that in normal monkeys. In MPTP-treated monkeys, subcutaneously injected SKF 38393, a dopamine D1 receptor agonist, significantly increased the bladder volume and pressure thresholds for inducing the micturition reflex without affecting those in normal monkeys. In contrast, subcutaneous injections of quinpirole, a dopamine D2 receptor agonist, and apomorphine, a dopamine D1 and D2 receptor agonist, slightly, but significantly reduced the volume threshold of the bladder for the micturition reflex in both normal and MPTP-treated groups. These results indicate that, in parkinsonism, the degeneration of dopaminergic neurons in the substantia nigra leads to the detrusor hyperreflexia, probably due to a failure of activation of dopamine D1 receptors.

References (23)

  • A.J. Pavlakis et al.

    Neurourologic findings in Parkinson's disease

    J. Urol.

    (1983)
  • Cited by (122)

    • The role of the autonomic nervous system in nocturnal enuresis

      2023, Journal of Pediatric Urology
      Citation Excerpt :

      Finally, the contribution in arousal, sleep, and micturition of other neurotransmitters involved in autonomic function, such as dopamine and serotonin has only recently been investigated, mainly in adult patients. Recent studies have demonstrated detrusor overactivity in patients with Parkinson's disease and monkeys in whom dopamine has been depleted [60,61]. Furthermore, dopamine deficiency is involved in the pathophysiology of PLMS mainly due to inhibition of spinal cord motor and sensory reflexes and increase of sympathetic tone [2].

    • Voluntary versus reflex micturition control

      2023, Neuro-Urology Research: A Comprehensive Overview
    • New Frontiers of Basic Science Research in Neurogenic Lower Urinary Tract Dysfunction

      2017, Urologic Clinics of North America
      Citation Excerpt :

      Fig. 5 shows a hypothetical diagram drawn from animal models of bladder dysfunction in PD. In monkeys, disruption of nigrostriatal dopaminergic pathways induced by the neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) produces PD-like motor symptoms accompanied by bladder overactivity shown by frequent urination with reduced voided volume.54–56 A rat model of PD induced by a unilateral 6-hydroxydopamine injection into the substantia nigra exhibits a similar type of bladder overactivity.57,58

    View all citing articles on Scopus
    View full text